Lotte Nedergaard

2.7k total citations
41 papers, 1.4k citations indexed

About

Lotte Nedergaard is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Lotte Nedergaard has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 16 papers in Obstetrics and Gynecology and 11 papers in Surgery. Recurrent topics in Lotte Nedergaard's work include Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Lotte Nedergaard is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Lotte Nedergaard collaborates with scholars based in Denmark, United States and Netherlands. Lotte Nedergaard's co-authors include Claus Høgdall, Estrid Høgdall, Lene Lundvall, Anne Kiil Berthelsen, Annika Loft, Svend Aage Engelholm, Signe Risum, Ib Jarle Christensen, Mona Aarenstrup Karlsen and T Haerslev and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Annals of Oncology.

In The Last Decade

Lotte Nedergaard

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotte Nedergaard Denmark 21 916 681 343 231 220 41 1.4k
Soon‐Beom Kang South Korea 24 692 0.8× 778 1.1× 223 0.7× 161 0.7× 354 1.6× 64 1.5k
Annika Auranen Finland 23 930 1.0× 492 0.7× 385 1.1× 109 0.5× 316 1.4× 72 1.6k
Thomas Högberg Sweden 21 1.1k 1.2× 939 1.4× 372 1.1× 44 0.2× 228 1.0× 52 1.5k
Camilla Nero Italy 22 660 0.7× 475 0.7× 335 1.0× 86 0.4× 289 1.3× 89 1.2k
Jamal Rahaman United States 18 571 0.6× 522 0.8× 252 0.7× 47 0.2× 163 0.7× 52 1.3k
S. Pecorelli Italy 4 895 1.0× 460 0.7× 456 1.3× 42 0.2× 284 1.3× 4 1.2k
Hitoshi Hareyama Japan 20 605 0.7× 842 1.2× 303 0.9× 49 0.2× 257 1.2× 42 1.3k
JL BENEDET Italy 8 1.4k 1.5× 1.4k 2.0× 598 1.7× 97 0.4× 427 1.9× 8 2.4k
N. Einhorn Sweden 15 559 0.6× 285 0.4× 317 0.9× 114 0.5× 199 0.9× 35 967
Isabelle Cadron Belgium 20 929 1.0× 648 1.0× 418 1.2× 31 0.1× 229 1.0× 43 1.4k

Countries citing papers authored by Lotte Nedergaard

Since Specialization
Citations

This map shows the geographic impact of Lotte Nedergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Nedergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Nedergaard more than expected).

Fields of papers citing papers by Lotte Nedergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Nedergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Nedergaard. The network helps show where Lotte Nedergaard may publish in the future.

Co-authorship network of co-authors of Lotte Nedergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Nedergaard. A scholar is included among the top collaborators of Lotte Nedergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Nedergaard. Lotte Nedergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Høgdall, Estrid, Claus Høgdall, Wei Zhou, et al.. (2017). PD-L1 expression and prognosis significance in advanced ovarian cancer. Annals of Oncology. 28. v333–v333. 1 indexed citations
2.
Høgdall, Estrid, Tine Henrichsen Schnack, Mona Aarenstrup Karlsen, et al.. (2016). High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population. Infectious Agents and Cancer. 11(1). 39–39. 25 indexed citations
3.
Karlsen, Mona Aarenstrup, Carsten Lindberg Fagö-Olsen, Estrid Høgdall, et al.. (2016). A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC–IV ovarian cancer—a part of the Danish prospective pelvic mass study. Tumor Biology. 37(9). 12619–12626. 18 indexed citations
4.
Karlsen, Mona Aarenstrup, et al.. (2016). Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT). Gynecologic Oncology. 142(1). 50–53. 30 indexed citations
5.
Prahm, Kira Philipsen, Mona Aarenstrup Karlsen, Estrid Høgdall, et al.. (2014). The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics. Gynecologic Oncology. 136(2). 205–211. 30 indexed citations
6.
7.
Risum, Signe, Annika Loft, Svend Aage Engelholm, et al.. (2012). Positron Emission Tomography/Computed Tomography Predictors of Overall Survival in Stage IIIC/IV Ovarian Cancer. International Journal of Gynecological Cancer. 22(7). 1163–1169. 23 indexed citations
8.
Heegaard, Niels H. H., Julia T. Tanassi, Gunnar Houen, et al.. (2012). Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival. PLoS ONE. 7(2). e30997–e30997. 11 indexed citations
9.
Høgdall, Claus, Eric T. Fung, Ib Jarle Christensen, et al.. (2011). A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer. Gynecologic Oncology. 123(2). 308–313. 21 indexed citations
10.
Rosendahl, Mikkel, Vera Timmermans Wielenga, Lotte Nedergaard, et al.. (2011). Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertility and Sterility. 95(6). 2158–2161. 77 indexed citations
11.
Høgdall, Estrid, Eric T. Fung, Ib Jarle Christensen, et al.. (2010). Proteomic biomarkers for overall and progression‐free survival in ovarian cancer patients. PROTEOMICS - CLINICAL APPLICATIONS. 4(12). 940–952. 25 indexed citations
12.
Risum, Signe, Claus Høgdall, Annika Loft, et al.. (2009). Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?. Gynecologic Oncology. 116(3). 395–398. 52 indexed citations
13.
Risum, Signe, Estrid Høgdall, Svend A. Engelholm, et al.. (2009). A Proteomics Panel for Predicting Optimal Primary Cytoreduction in Stage III/IV Ovarian Cancer. International Journal of Gynecological Cancer. 19(9). 1535–1538. 5 indexed citations
14.
Eiberg, Hans, Peder Kern, Bent Ejlertsen, et al.. (2009). A high frequent BRCA1 founder mutation identified in the Greenlandic population. Familial Cancer. 8(4). 413–419. 22 indexed citations
15.
Risum, Signe, Claus Høgdall, Annika Loft, et al.. (2007). The diagnostic value of PET/CT for primary ovarian cancer—A prospective study. Gynecologic Oncology. 105(1). 145–149. 120 indexed citations
16.
Loft, Annika, Anne Kiil Berthelsen, Henrik Roed, et al.. (2007). The diagnostic value of PET/CT scanning in patients with cervical cancer: A prospective study. Gynecologic Oncology. 106(1). 29–34. 125 indexed citations
17.
Jacobsen, Magnus W., et al.. (1997). Endometrial Carcinomas - Flow Cytometric DNA Content and S-phase Values. Pathology - Research and Practice. 193(4). 283–290. 4 indexed citations
18.
Nedergaard, Lotte, Lise Christensen, Birgitte Buur Rasmussen, & Grete Krag Jacobsen. (1996). Comparison of Two Monoclonal Antibodies for the Detection of Estrogen Receptors in Primary Breast Carcinomas. Pathology - Research and Practice. 192(10). 983–988. 5 indexed citations
19.
Nedergaard, Lotte, Marianne Jacobsen, & Jørn Andersen. (1995). Interobserver agreement for tumour type, grade of differentiation and stage in endometrial carcinomas. Apmis. 103(7-8). 511–518. 30 indexed citations
20.
Vangsted, Annette Juul, Elo Andersen, Lotte Nedergaard, & Jesper Zeuthen. (1991). Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer. Breast Cancer Research and Treatment. 19(2). 119–128. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soon‐Beom Kang Breakdown of academic impact, for papers by Annika Auranen Breakdown of academic impact, for papers by Thomas Högberg Breakdown of academic impact, for papers by Camilla Nero Breakdown of academic impact, for papers by Jamal Rahaman Breakdown of academic impact, for papers by S. Pecorelli Breakdown of academic impact, for papers by Hitoshi Hareyama Breakdown of academic impact, for papers by JL BENEDET Breakdown of academic impact, for papers by N. Einhorn Breakdown of academic impact, for papers by Isabelle Cadron
Rankless by CCL
2026